Global Immunotherapy Drugs 2016-2020 Prevention, Management, Mechanisms, Cause and Symptoms Report

Global Immunotherapy Drugs 2016-2020 Size and Share Published in 2016-03-29 Available for US$ 2500 at Researchmoz.us

Description

Immunotherapy enhances the innate powers of the immune system. The properties of the immune system to fight abnormal cells give immunotherapy drugs the chance of successfully fighting diseases such as cancer, respiratory, infectious, and autoimmune disorders.

Technavios analysts forecast the global immunotherapy drugs market to grow at a CAGR of 11.52% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global immunotherapy drugs market for the period 2015-2020. To calculate the market size, the report considers revenue generated from the sales of immunotherapy drugs used to treat cancer, respiratory, infectious, autoimmune, and inflammatory diseases. It also considers the revenues to be generated from the sales of drugs, which are expected to be launched into the market, along with the decline in revenues from the patent expiries of marketed drugs during the forecast period.

The market is divided into the following segments based on geography:

Americas

APAC

EMEA

Download Sample of this Report at: http://www.researchmoz.us/enquiry.php?type=S&repid=685210

Technavio's report, Global Immunotherapy Drugs Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

AbbVie Inc.

Amgen Inc.

Bristol-Myers Squibb Company (BMS)

F. Hoffmann-La Roche AG

Johnson & Johnson Private Ltd.

Merck & Co. Inc.

Other prominent vendors

AB Science

Ablynx

Acorda Therapeutics

ADC Therapeutics

Aduro Biotech

Advantagene

Advaxis

Agensys Inc.

Agenus Inc.

Alder Biopharmaceuticals

AlphaVax

Altor BioScience

Antares Pharma

Antigen Express

Argos Therapeutics Inc.

Astellas Pharma

AstraZeneca

AVAX Technologies

Bavarian Nordic

Baxter

Bayer

Biogen

Biotech Pharmaceutical

Biothera

Boehringer Ingelheim

Can-Fite BioPharma

Celgene

Celldex Therapeutics

Celltrion

Cel-Sci

ChemoCentryx

Chugai Pharmaceutical

Coherus BioSciences

CTI BioPharma

CureVac

Cytos Biotechnology

Daiichi Sankyo

Eisai

Eli Lilly

Fortress Biotech

Galena Biopharma

Genexine

Genmab

Gilead Sciences

GSK

GlobeImmune

Gradalis

Heat Biologics

Hospira

Idera

Immatics

ImmunoCellular Therapeutics

Immunomedics

ImmuPharma

Immutep

Incyte

Inovio Pharmaceuticals

Intas Pharmaceuticals

Invion

ISA Pharmaceuticals

Janssen Biotech

Juvaris Biotherapeutics

KaloBios Pharmaceuticals

Kyowa Hakko Kirin

Lexicon Pharmaceuticals

MedImmune

Morphotek

Neovii Biotech

Northwest Biotherapeutics

Novartis

NovaRx

Novo Nordisk

OncoMed Pharmaceuticals

Oncothyreon

Oncovir Inc.

Opexa Therapeutics Inc.

Oxford BioMedica

Pfizer

Prima BioMed

Principia

Progenics

Provectus Biopharmaceuticals

Regeneron

Sandoz

Sanofi

Santarus

Seattle Genetics

Sotio

Spectrum Pharmaceuticals

Takeda

TG Therapeutics

Transgene

UbiVac

UCB

Vaccinex

Vaccinogen

Vaxon Biotech

Vertex Pharmaceuticals

Vical

Vitae Pharmaceuticals

XBiotech

Market driver

Growing prevalence of cancer and autoimmune diseases

For a full, detailed list, view our report

Market challenge

Patent expiries of top-selling drugs

For a full, detailed list, view our report

Market trend

Increase in awareness programs

For a full, detailed list, view our report

Key questions answered in this report

What will the market size be in 2020 and what will the growth rate be?

What are the key market trends?

What is driving this market?

What are the challenges to market growth?

Who are the key vendors in this market space?

What are the market opportunities and threats faced by the key vendors?

What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analysts time when you purchase this market report. Details are provided within the report.

Make an Enquiry: http://www.researchmoz.us/enquiry.php?type=E&repid=685210

Table of Content

PART 01: Executive summary

Highlights

PART 02: Scope of the report

Market overview

Top-vendor offerings

Assumptions

PART 03: Market research methodology

Research methodology

Economic indicators

PART 04: Introduction

Key market highlights

PART 05: Overview: Immunotherapy

Types of immunotherapy

Key events

Reimbursement policies

Orphan drug designation and regulatory approvals

PART 06: Pipeline portfolio

Anticipated number of immuno-oncology pipeline assets with single and multiple indications by 2020

PART 07: Market landscape

Market overview

Market size and forecast

Five forces analysis

Browse All Healthcare Market Research Reports at: http://www.researchmoz.us/healthcare-market-reports-56.html

About ResearchMoz

ResearchMoz is the world’s fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives.

Contact Us:

ResearchMoz
Mr. Nachiket Ghumare, +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
sales@researchmoz.us
http://www.researchmoz.us/